Teladoc Health, Inc. (NYSE:TDOC) Insider Sells $132,115.59 in Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Laizer Kornwasser sold 10,411 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Laizer Kornwasser also recently made the following trade(s):

• On Friday, February 2nd, Laizer Kornwasser sold 7,882 shares of Teladoc Health stock. The stock was sold at an average price of $19.18, for a total value of $151,176.76.

Teladoc Health Stock Down 1.6 %

TDOC opened at $12.78 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.47 and a current ratio of 3.82. Teladoc Health, Inc. has a 1-year low of $12.53 and a 1-year high of $30.41. The business has a 50 day moving average price of $14.40 and a two-hundred day moving average price of $17.51.

Teladoc Health (NYSE:TDOC) last released its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.37) earnings per share. Research analysts anticipate that Teladoc Health, Inc. will post -1.04 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of the stock. ARK Investment Management LLC lifted its position in shares of Teladoc Health by 4.5% during the 4th quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock valued at $457,389,000 after acquiring an additional 912,692 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after acquiring an additional 1,855,480 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Teladoc Health by 25.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after acquiring an additional 767,999 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Teladoc Health by 6.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,116 shares of the health services provider’s stock valued at $35,646,000 after acquiring an additional 104,531 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in shares of Teladoc Health by 9.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 658,435 shares of the health services provider’s stock valued at $12,240,000 after acquiring an additional 57,989 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Stifel Nicolaus dropped their target price on Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 26th. Canaccord Genuity Group dropped their target price on Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, April 26th. Evercore ISI dropped their target price on Teladoc Health from $15.00 to $14.00 and set an “in-line” rating on the stock in a research report on Friday, April 26th. Truist Financial dropped their target price on Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research report on Friday, April 26th. Twelve equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and a consensus target price of $18.73.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.